On April 1, 2022, the Centers for Disease Control and Prevention (CDC) published updated recommendations for universal hepatitis B vaccination in adults aged 19-59 years. The recommendation removes the risk factor assessment previously in place for adults in this age group. A universal recommendation will simplify the hepatitis B recommendation for both vaccine recipients and clinicians, with the hope to increase hepatitis B vaccination coverage and decrease hepatitis B infection.